5049-61-6 = 873-42-7 + 6863-73-6 + 33332-29-5 反应条件:1.1 Reagents: Chlorosuccinimide Solvents: Acetonitrile; 3 H,100 °C 标题:Efficient Halogenation Of 2-Aminopyrazine 作者:Lizano,Enric; Et Al 参考文献:Synlett 日期:2019 卷标:30(17) 页码:2000-2003]
6863-73-6 = 873-42-7 反应条件:1.1 Reagents: Lithium Chloride,Selectfluor Solvents: Dimethylformamide; 12 H,15 °C 标题:Selectfluor-Promoted Regioselective Chlorination/bromination Of 2-Aminopyridines And 2-Aminodiazines Using Licl/libr 作者:Hu,Jiao; Et Al 参考文献:Organic & Biomolecular Chemistry 日期:2019 卷标:17(26) 页码:6342-6345]
5049-61-6 = 873-42-7 反应条件:1.1 Reagents: 1-Chloro-3H-1,2-Benziodoxol-3-One Solvents: Dimethylformamide; 12 H,60 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water 标题:Story Of An Age-Old Reagent: An Electrophilic Chlorination Of Arenes And Heterocycles By 1-Chloro-1,2-Benziodoxol-3-One 作者:Wang,Mengzhou; Et Al 参考文献:Organic Letters 日期:2016 卷标:18(9) 页码:1976-1979]
5049-61-6 = 873-42-7 反应条件:1.1 Reagents: Chlorosuccinimide Solvents: Tetrahydrofuran; 10 H,100 °C 标题:Synthesis Of N-Substituted 2-Aminothiazolo[4,5-B]Pyrazines By Tandem Reaction Of O-Aminohalopyrazines With Isothiocyanates 作者:Kwak,Se Hun; Et Al 参考文献:Bulletin Of The Korean Chemical Society 日期:2012 卷标:33(12) 页码:4271-4274]
5049-61-6 = 873-42-7 + 13484-51-0 反应条件:1.1 Reagents: Chlorosuccinimide Solvents: Acetonitrile; 72 H,Rt 标题:Efficient Halogenation Of 2-Aminopyrazine 作者:Lizano,Enric; Et Al 参考文献:Synlett 日期:2019 卷标:30(17) 页码:2000-2003
专利号:US-3158612-A 优先权日:1961-11-03 标 题 :Synthesis of 2-amino-3-methoxy 5-chloro pyrazine 发明人:LUIGI BERNARDI; GIOVANNI LARINI; ANSELMO LEONE 权利人:FARMACEUTICI ITALIA
专利号:US-10766863-B2 优先权日:2014-11-17 标 题 :Monocarboxylate transport modulators and uses thereof 发明人:SANDANAYAKA VINCENT; WU QIONG 权利人:NIROGYONE THERAPEUTICS INC 摘要:The invention generally relates to the field of monocarboxylate transport modulators, e.g., monocarboxylate transport inhibitors, and more particularly to new substituted-quinolone compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in treating, modulating, forestalling and/or reducing physiological conditions associated with monocarboxylate transport activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, obesity, diabetes, cardiovascular diseases, tissue and organ transplant rejection, and malaria.
专利号:CN-113234029-B 优先权日:2021-05-25 标 题 :Synthesis method of 2-amino-3, 5-dihalogen pyrazine
参考文献:10.1021/acs.jmedchem.3c02118 摘要:Day JEH, Berdini V, Castro J, Chessari G, Davies TG, Day PJ, St Denis JD, Fujiwara H, Fukaya S, Hamlett CCF, Hearn K, Hiscock SD, Holvey RS, Ito S, Kandola N, Kodama Y, Liebeschuetz JW, Martins V, Matsuo K, Mortenson PN, Muench S, Nakatsuru Y, Ochiiwa H, Palmer N, Peakman T, Price A, Reader M, Rees DC, Rich SJ, Shah A, Shibata Y, Smyth T, Twigg DG, Wallis NG, Williams G, Wilsher NE, Woodhead A, Shimamura T, Johnson CN. Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2). J Med Chem. 2024 Mar 28;67(6):4655–75. doi: 10.1021/acs.jmedchem.3c02118.